The Role of BCG Vaccine in the Clinical Evolution of COVID-19 and in the Efficacy of Anti-SARS-CoV-2 Vaccines
Clinical trial NCT05507671 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05507671
- Sponsor
- Oswaldo Cruz Foundation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-27
- Primary completion
- 2023-07-31
- Enrollment
- 556
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.